Unknown

Dataset Information

0

Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus.


ABSTRACT:

Background

Small retrospective series suggest that local consolidative treatment (LCT) may improve survival in oligometastatic pancreatic ductal adenocarcinoma (PDAC). However, no uniform definition of oligometastatic disease (OMD) in PDAC exists; this impedes meaningful conclusions.

Patients and methods

A systematic literature search using PubMed, Web of Science, and Cochrane CENTRAL registries for studies and protocols reporting on definitions and/or LCT of OMD in PDAC was performed. The primary endpoint was the definition of OMD. Levels of agreement were categorized as consensus (≥75% agreement between studies), fair agreement (50%-74%), and absent/poor agreement (<50%).

Results

After screening of 5374 abstracts, the full text of 218 studies was assessed, of which 76 were included in the qualitative synthesis. The majority of studies were retrospective (n = 66, 87%), two were prospective studies and eight were study protocols. Studies investigated mostly liver (n = 38, 51%) and lung metastases (n = 15, 20%). Across studies, less than one-half (n = 32, 42%) reported a definition of OMD, while 44 (58%) did not. Involvement was limited to a single organ (consensus). Additional criteria for defining OMD were the number of lesions (consensus), metastatic site (poor agreement), metastatic size (poor agreement), treatment possibilities (poor agreement), and biomarker response (poor agreement). Liver OMD could involve three or fewer lesions (consensus) and synchronous disease (fair agreement), while lung metastases could involve two or fewer lesions and metachronous disease (consensus). The large majority of studies were at a high risk of bias or did not include any control groups.

Conclusion

Definitions of OMD were not used or varied widely between studies hampering across-study comparability and highlighting an unmet need for a consensus. The present study is part of a multistep process that aims to develop an interdisciplinary consensus on OMD in pancreatic cancer.

SUBMITTER: Leonhardt CS 

PROVIDER: S-EPMC10774968 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus.

Leonhardt C-S CS   Stamm T T   Hank T T   Prager G G   Strobel O O  

ESMO open 20231120 6


<h4>Background</h4>Small retrospective series suggest that local consolidative treatment (LCT) may improve survival in oligometastatic pancreatic ductal adenocarcinoma (PDAC). However, no uniform definition of oligometastatic disease (OMD) in PDAC exists; this impedes meaningful conclusions.<h4>Patients and methods</h4>A systematic literature search using PubMed, Web of Science, and Cochrane CENTRAL registries for studies and protocols reporting on definitions and/or LCT of OMD in PDAC was perfo  ...[more]

Similar Datasets

| S-EPMC10468799 | biostudies-literature
| S-EPMC8350082 | biostudies-literature
| S-EPMC9452425 | biostudies-literature
| S-EPMC6380642 | biostudies-literature
| S-EPMC9131772 | biostudies-literature
| S-EPMC7106565 | biostudies-literature
| S-EPMC6937989 | biostudies-literature
| S-EPMC7296190 | biostudies-literature
| S-EPMC9089416 | biostudies-literature
| S-EPMC4809106 | biostudies-other